Huy Ngo

1.1k total citations
43 papers, 812 citations indexed

About

Huy Ngo is a scholar working on Oncology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Huy Ngo has authored 43 papers receiving a total of 812 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Huy Ngo's work include Advanced Breast Cancer Therapies (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Bone Tissue Engineering Materials (4 papers). Huy Ngo is often cited by papers focused on Advanced Breast Cancer Therapies (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Bone Tissue Engineering Materials (4 papers). Huy Ngo collaborates with scholars based in United States, Netherlands and Japan. Huy Ngo's co-authors include Sylvie Garneau‐Tsodikova, Sanjib K. Shrestha, Nishad Thamban Chandrika, Keith Green, Oleg V. Tsodikov, Jingjing Sha, Tatsuo Okui, Takahiro Kanno, Ling Zou and Kathleen M. Giacomini and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The FASEB Journal.

In The Last Decade

Huy Ngo

38 papers receiving 804 citations

Peers

Countries citing papers authored by Huy Ngo

Since Specialization

Citations

This map shows the geographic impact of Huy Ngo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huy Ngo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huy Ngo more than expected).

Fields of papers citing papers by Huy Ngo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huy Ngo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huy Ngo. The network helps show where Huy Ngo may publish in the future.

Co-authorship network of co-authors of Huy Ngo

This figure shows the co-authorship network connecting the top 25 collaborators of Huy Ngo. A scholar is included among the top collaborators of Huy Ngo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huy Ngo. Huy Ngo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AI for rapid identification of major butyrate-producing bacteria in rhesus macaques (Macaca mulatta) 2025 ·Animal Microbiome ·(unknown), (unknown), Huy Ngo, R.C. Montijn, Jaco Bakker, Jan A. M. Langermans, Evgeni Levin	0
2	Interim analysis (IA) of the giredestrant (G) + everolimus (EVERO) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with estrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC). 2024 ·Journal of Clinical Oncology ·Seth A. Wander, Salomon M. Stemmer, Hope S. Rugo, Seock‐Ah Im, Peter K. H. Lau, Shani Paluch–Shimon, (unknown), (unknown), Mona D. Shah, Huy Ngo, Richard B. Schwab, Jing Zhu, Mafalda Oliveira	0
3	365P Interim analysis (IA) of the giredestrant (G) + samuraciclib (SAMURA) arm in MORPHEUS breast cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC) 2024 ·Annals of Oncology ·Mafalda Oliveira, (unknown), Kyung Hae Jung, (unknown), Sara A. Hurvitz, (unknown), Seth A. Wander, S-A Im, (unknown), Jia Zhu, Richard B. Schwab, Huy Ngo, (unknown), Mary Cannon, (unknown), (unknown), Steven McIntosh, Cristina Saavedra, Amir Sonnenblick	1
4	Oncology Dose Selection in Subsequent Indications: What Can We Learn From FDA-approved Oncology Drugs? 2024 ·Clinical Therapeutics ·Huy Ngo, (unknown), Chunze Li, Jiajie Yu	0
5	A rapid, affordable, and reliable method for profiling microbiome biomarkers from fecal images 2024 ·iScience ·(unknown), (unknown), Huy Ngo, R.C. Montijn, Jaco Bakker, Jan A. M. Langermans, Evgeni Levin	3
6	395P Interim analysis (IA) of the giredestrant (G) + ipatasertib (IPAT) arm in MORPHEUS Breast Cancer (BC): A phase I/II study of G treatment (tx) combinations in patients (pts) with oestrogen receptor-positive (ER+), HER2-negative, locally advanced/metastatic BC (LA/mBC) 2023 ·Annals of Oncology ·Kyung Hae Jung, Stephen J. Luen, Mafalda Oliveira, Joohyuk Sohn, S-A Im, Seth A. Wander, Sara A. Hurvitz, Amir Sonnenblick, (unknown), (unknown), (unknown), Huy Ngo, Richard B. Schwab, Colby S. Shemesh, Jia Zhu, (unknown)	1
7	Blocking insulin-like growth factor 1 receptor signaling pathway inhibits neuromuscular junction regeneration after botulinum toxin-A treatment 2023 ·Cell Death and Disease ·Hiroki Ishihara, (unknown), (unknown), (unknown), Huy Ngo, Masashi Fujitani	5
8	First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants 2023 ·Acta Obstetricia Et Gynecologica Scandinavica ·(unknown), Veerle L.B. Jaspers, Reinier Akkermans, B.F.M. Slangen, Angèle L.M. Oei, (unknown), Huy Ngo, Joanna IntHout, Rosella Hermens, Joanne A. de Hullu, Jurgen M.J. Piek	6
9	Inhibition of Pseudomonas aeruginosa Alginate Synthesis by Ebselen Oxide and Its Analogues 2021 ·ACS Infectious Diseases ·(unknown), Huy Ngo, Emily K. Dennis, Nishad Thamban Chandrika, Philip DeShong, Sylvie Garneau‐Tsodikova, Vincent T. Lee	15
10	The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2 2021 ·The AAPS Journal ·(unknown), (unknown), Bianca Vora, Huy Ngo, Sook Wah Yee, (unknown), Marina Sirota, Kathleen M. Giacomini	2
11	Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3 2020 ·Journal of Pharmaceutical Sciences ·Ling Zou, Pär Matsson, Adrian Stecuła, Huy Ngo, Arik A. Zur, Kathleen M. Giacomini	17
12	Deorphaning a solute carrier 22 family member, SLC22A15, through functional genomic studies 2020 ·The FASEB Journal ·Sook Wah Yee, (unknown), Adrian Stecuła, Huy Ngo, Huan‐Chieh Chien, Ling Zou, (unknown), Kathleen M. Giacomini	32
13	Structure-Guided Optimization of Inhibitors of Acetyltransferase Eis from Mycobacterium tuberculosis 2020 ·ACS Chemical Biology ·(unknown), Huy Ngo, (unknown), Keith Green, Melisa J. Willby, Shilah A. Bonnett, (unknown), Emily K. Dennis, James E. Posey, Tanya Parish, Oleg V. Tsodikov, Sylvie Garneau‐Tsodikova	18
14	Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study 2019 ·Journal of Gynecologic Oncology ·Casper Reijnen, Nicole C.M. Visser, (unknown), Dorry Boll, Peggy M. A. J. Geomini, Huy Ngo, Dennis van Hamont, Brenda Pijlman, M. Caroline Vos, Johan Bulten, Marc P.L.M. Snijders, Leon F.A.G. Massuger, Johanna M.A. Pijnenborg	33
15	N,N′-diaryl-bishydrazones in a biphenyl platform: Broad spectrum antifungal agents 2018 ·European Journal of Medicinal Chemistry ·Nishad Thamban Chandrika, Emily K. Dennis, Sanjib K. Shrestha, Huy Ngo, Keith Green, Stefan Kwiatkowski, Agripina G. Deaciuc, Linda P. Dwoskin, David S. Watt, Sylvie Garneau‐Tsodikova	13
16	Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade 2018 ·Gynecological Surgery ·(unknown), Nicole P. M. Ezendam, Florine A. Eggink, (unknown), Dennis van Hamont, Brenda Pijlman, Erik A. Boss, (unknown), Huy Ngo, Dorry Boll, Constantijne H. Mom, Maaike A. van der Aa, (unknown), Hans W. Nijman, Johanna M.A. Pijnenborg	5
17	Developing antineoplastic agents that target peroxisomal enzymes: cytisine-linked isoflavonoids as inhibitors of hydroxysteroid 17-beta-dehydrogenase-4 (HSD17B4) 2017 ·Organic & Biomolecular Chemistry ·M. S. Frasinyuk, Wen Zhang, (unknown), Tianxin Yu, (unknown), Vitaliy M. Sviripa, S. P. Bondarenko, Yanqi Xie, Huy Ngo, Andrew J. Morris, James L. Mohler, Michael V. Fiandalo, David S. Watt, Chunming Liu	25
18	Novel fluconazole derivatives with promising antifungal activity 2017 ·Bioorganic & Medicinal Chemistry ·Nishad Thamban Chandrika, Sanjib K. Shrestha, Huy Ngo, (unknown), Sylvie Garneau‐Tsodikova	28
19	Synthesis and investigation of novel benzimidazole derivatives as antifungal agents 2016 ·Bioorganic & Medicinal Chemistry ·Nishad Thamban Chandrika, Sanjib K. Shrestha, Huy Ngo, Sylvie Garneau‐Tsodikova	118
20	Development of ebsulfur analogues as potent antibacterials against methicillin-resistant Staphylococcus aureus 2016 ·Bioorganic & Medicinal Chemistry ·Huy Ngo, Sanjib K. Shrestha, Keith Green, Sylvie Garneau‐Tsodikova	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact